$EHTH
eHealth, Inc. Stock $ehth

$ehth Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000133349314000060 Filed on August 08, 2014

Income Statement

Concept	2014 Q2	2013 Q2
Revenue	$42.59M	$39.80M
YoY Change	7.02%	12.11%
Cost Of Revenue	$892.0K	$984.0K
YoY Change	-9.35%	23.0%
Gross Profit	$41.70M	$38.82M
YoY Change	7.44%	11.86%
Gross Profit Margin	97.91%	97.53%
Selling, General & Admin	$35.00M	$36.40M
YoY Change	-3.85%	20.93%
% of Gross Profit	83.93%	93.78%
Research & Development	$9.550M	$7.727M
YoY Change	23.59%
% of Gross Profit	22.9%	19.91%
Depreciation & Amortization	$1.420M	$1.110M
YoY Change	27.93%	12.12%
% of Gross Profit	3.41%	2.86%
Operating Expenses	$9.550M	$7.727M
YoY Change	23.59%	-74.75%
Operating Profit	$6.348M	$2.031M
YoY Change	212.56%	-50.46%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$29.00K	-$21.00K
YoY Change	38.1%
Pretax Income	$6.319M	$2.010M
YoY Change	214.38%	-52.14%
Income Tax	$3.296M	$864.0K
% Of Pretax Income	52.16%	42.99%
Net Earnings	$3.023M	$1.146M
YoY Change	163.79%	-50.17%
Net Earnings / Revenue	7.1%	2.88%
Basic Earnings Per Share	$0.16	$0.06
Diluted Earnings Per Share	$0.15	$0.06
COMMON SHARES
Basic Shares Outstanding	18.98M shares	18.95M shares
Diluted Shares Outstanding	19.78M shares	19.50M shares

Balance Sheet

Concept	2014 Q2	2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$70.40M	$89.70M
YoY Change	-21.52%	-26.54%
Cash & Equivalents	$70.38M	$89.71M
Short-Term Investments
Other Short-Term Assets	$12.60M	$13.50M
YoY Change	-6.67%	32.35%
Inventory
Prepaid Expenses
Receivables	$6.863M	$1.600M
Other Receivables	$5.800M	$3.700M
Total Short-Term Assets	$89.85M	$108.6M
YoY Change	-17.26%	-20.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.59M	$9.500M
YoY Change	11.52%	63.79%
Goodwill	$14.10M
YoY Change
Intangibles	$11.60M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.195M	$10.70M
YoY Change	-51.45%	-17.69%
Total Long-Term Assets	$47.62M	$42.50M
YoY Change	12.05%	0.0%
TOTAL ASSETS
Total Short-Term Assets	$89.85M	$108.6M
Total Long-Term Assets	$47.62M	$42.50M
Total Assets	$137.5M	$151.1M
YoY Change	-9.02%	-15.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.153M	$5.400M
YoY Change	-23.09%	45.95%
Accrued Expenses	$9.400M	$11.10M
YoY Change	-15.32%	16.84%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$17.51M	$20.70M
YoY Change	-15.43%	21.05%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$5.900M	$6.000M
YoY Change	-1.67%	50.0%
Total Long-Term Liabilities	$5.873M	$6.000M
YoY Change	-2.12%	50.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.51M	$20.70M
Total Long-Term Liabilities	$5.873M	$6.000M
Total Liabilities	$23.38M	$26.70M
YoY Change	-12.43%	25.94%
SHAREHOLDERS EQUITY
Retained Earnings	$31.94M
YoY Change
Common Stock	$29.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$178.3M	$150.0M
YoY Change	18.84%	66.67%
Treasury Stock Shares	10.08M shares	$9.309M
Shareholders Equity	$114.1M	$124.4M
YoY Change
Total Liabilities & Shareholders Equity	$137.5M	$151.1M
YoY Change	-9.02%	-15.3%

Cashflow Statement

Concept	2014 Q2	2013 Q2
OPERATING ACTIVITIES
Net Income	$3.023M	$1.146M
YoY Change	163.79%	-50.17%
Depreciation, Depletion And Amortization	$1.420M	$1.110M
YoY Change	27.93%	12.12%
Cash From Operating Activities	$310.0K	$6.640M
YoY Change	-95.33%	-13.09%
INVESTING ACTIVITIES
Capital Expenditures	-$1.220M	-$2.280M
YoY Change	-46.49%	16.92%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$1.220M	-$2.280M
YoY Change	-46.49%	-40.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-26.93M	-28.24M
YoY Change	-4.64%	-1519.1%
NET CHANGE
Cash From Operating Activities	310.0K	6.640M
Cash From Investing Activities	-1.220M	-2.280M
Cash From Financing Activities	-26.93M	-28.24M
Net Change In Cash	-27.84M	-23.88M
YoY Change	16.58%	-510.31%
FREE CASH FLOW
Cash From Operating Activities	$310.0K	$6.640M
Capital Expenditures	-$1.220M	-$2.280M
Free Cash Flow	$1.530M	$8.920M
YoY Change	-82.85%	-6.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	1105000	USD
CY2013Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	2322000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4381000	USD
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	4153000	USD
CY2014Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6863000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4586000	USD
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	177000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	160000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	252361000	USD
CY2014Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	260207000	USD
	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	3900000	USD
CY2014Q2	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	400000	USD
CY2013Q2	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	500000	USD
	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	3700000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4295000	USD
CY2014Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1850000	USD
CY2013Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1782000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3416000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	708000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	27000	shares
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	707000	USD
CY2013Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	353000	USD
CY2014Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	354000	USD
CY2013Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	302000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	318000	shares
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	195000	shares
CY2014Q2	us-gaap	Assets Assets	137475000	USD
CY2013Q4	us-gaap	Assets Assets	166426000	USD
CY2014Q2	us-gaap	Assets Current AssetsCurrent	89854000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	124464000	USD
CY2013Q4	us-gaap	Cash Cash	16935000	USD
CY2014Q2	us-gaap	Cash Cash	33761000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	70382000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	107055000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	140849000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	89713000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-36673000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-51136000	USD
CY2013Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	90120000	USD
CY2014Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	36621000	USD
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	29000	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	28000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3024000	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1131000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1487000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3489000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	3005000	USD
CY2013Q2	us-gaap	Cost Of Revenue CostOfRevenue	984000	USD
CY2014Q2	us-gaap	Cost Of Revenue CostOfRevenue	892000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	3635000	USD
CY2014Q2	us-gaap	Costs And Expenses CostsAndExpenses	36246000	USD
CY2013Q2	us-gaap	Costs And Expenses CostsAndExpenses	37769000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	77035000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	90296000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3449000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2035000	USD
CY2014Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1512000	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1784000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	4459000	USD
CY2014Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	4962000	USD
CY2014Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	6141000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	3926000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	3663000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5880000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6588000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1384000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	4569000	USD
	us-gaap	Depreciation Depreciation	2061000	USD
	us-gaap	Depreciation Depreciation	1390000	USD
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	13000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-12000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.536
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.408
CY2014Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.522
CY2013Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.430
CY2014Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7235000	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	10291000	USD
	us-gaap	Employee Service Share Based Compensation Cash Flow Effect Cash Used To Settle Awards EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards	-3355000	USD
	us-gaap	Employee Service Share Based Compensation Cash Flow Effect Cash Used To Settle Awards EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards	-842000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	707000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1052000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1075000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1075000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1188000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	13069000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	13069000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6481000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7189000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15151000	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6857000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14651000	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7132000	USD
CY2014Q2	us-gaap	Goodwill Goodwill	14096000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	14096000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5926000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2010000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3170000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6319000	USD
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	864000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1700000	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3296000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2419000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1541000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-227000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2277000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	866000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-603000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	887000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-530000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-3051000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-123000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	952000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1176000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1073000	USD
CY2014Q1	us-gaap	Indefinitelived Intangible Assets Acquired IndefinitelivedIntangibleAssetsAcquired	4800000	USD
CY2013Q2	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	34942000	USD
CY2014Q2	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	38526000	USD
	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	84103000	USD
	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	73193000	USD
CY2014Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11595000	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7496000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	166426000	USD
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	137475000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	27244000	USD
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	17507000	USD
CY2014Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5873000	USD
CY2013Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	6165000	USD
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	28596000	USD
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	32718000	USD
CY2013Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	13761000	USD
CY2014Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	9609000	USD
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Description of Business—</font><font style="font-family:inherit;font-size:10pt;">eHealth, Inc. (the “Company,” “eHealth,” “we” or “us”) is the leading online source of health insurance for individuals, families and small businesses in the United States. Through our website addresses (</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">www.eHealth.com</font><font style="font-family:inherit;font-size:10pt;">,  </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">www.eHealthInsurance.com</font><font style="font-family:inherit;font-size:10pt;">,  </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">www.eHealthMedicare.com, www.Medicare.com</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">www.PlanPrescriber.com)</font><font style="font-family:inherit;font-size:10pt;">, consumers can get quotes from leading health insurance carriers, compare plans side-by-side, and apply for and purchase individual and family, Medicare-related, small business and ancillary health insurance plans. We actively market the availability of Medicare-related insurance plans and offer Medicare plan comparison tools and educational materials for Medicare-related insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans.  Our ecommerce technology also enables us to deliver consumers’ health insurance applications electronically to health insurance carriers. As a result, we simplify and streamline the complex and traditionally paper-intensive health insurance sales and purchasing process. We are licensed to market and sell health insurance in all </font><font style="font-family:inherit;font-size:10pt;">50</font><font style="font-family:inherit;font-size:10pt;"> states and the District of Columbia. </font></div></div>
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-24744000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-53400000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6840000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3821000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5102000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6097000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	1146000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	3023000	USD
	us-gaap	Net Income Loss NetIncomeLoss	1470000	USD
	us-gaap	Net Income Loss NetIncomeLoss	3507000	USD
CY2014Q2	us-gaap	Noncurrent Assets NoncurrentAssets	41480000	USD
CY2013Q4	us-gaap	Noncurrent Assets NoncurrentAssets	37393000	USD
CY2014Q2	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	50	state
	us-gaap	Operating Income Loss OperatingIncomeLoss	5972000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	2031000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	6348000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	3238000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5518000	USD
CY2014Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5195000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-15000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	17000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-18000	USD
CY2013Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2561000	USD
CY2014Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2466000	USD
CY2013Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-21000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-68000	USD
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-29000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-46000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	59007000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	28256000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4500000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2014Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4500000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3821000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2340000	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8364000	USD
CY2014Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7647000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3244000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2549000	USD
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10594000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10283000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	40000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	26000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	1968000	USD
CY2013Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	1126000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	3089000	USD
CY2014Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	1286000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	30466000	USD
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	31936000	USD
CY2013Q2	us-gaap	Revenues Revenues	39800000	USD
CY2014Q2	us-gaap	Revenues Revenues	42594000	USD
	us-gaap	Revenues Revenues	93534000	USD
	us-gaap	Revenues Revenues	83007000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4295000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3416000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	7000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	19.33
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	458000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	40.78
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	779000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1027000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	29.16
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	19.57
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y3M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y6M16D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	203000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	18.96
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2000000	USD
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	769332	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.459
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.459
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.397
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.397
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0062
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0142
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0062
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0142
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	751000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	4500000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	4277000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	4085000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	15000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	25000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.32
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	17.01
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	17.01
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.32
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	36220000	USD
CY2014Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	39010000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y3M18D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y2M12D
CY2014Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y2M12D
CY2013Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y3M18D
CY2013Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	700000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1200000	USD
CY2014Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	500000	USD
CY2013Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	656000	USD
CY2014Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	564000	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1206000	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1448000	USD
	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	50000000	USD
CY2012Q3	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	30000000	USD
CY2013	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	60000000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	133017000	USD
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	114095000	USD
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	36.73
CY2013	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	20.29
CY2013Q4	us-gaap	Treasury Stock Number Of Shares Held TreasuryStockNumberOfSharesHeld	9519286	shares
CY2014Q2	us-gaap	Treasury Stock Number Of Shares Held TreasuryStockNumberOfSharesHeld	10354094	shares
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	9309269	shares
CY2014Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	10078601	shares
	ehth	Increase Decrease In Deferred Rent Expense IncreaseDecreaseInDeferredRentExpense	827000	USD
CY2013	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	2957179	shares
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	149998000	USD
CY2014Q2	us-gaap	Treasury Stock Value TreasuryStockValue	178254000	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	28256000	USD
CY2013	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	60000000	USD
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19775000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20324000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19496000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19821000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18946000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19754000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18914000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18978000	shares
CY2014Q1	ehth	Accounts Receivable Associated With Acquisition Of Intangible Assets AccountsReceivableAssociatedWithAcquisitionOfIntangibleAssets	300000	USD
CY2014Q2	ehth	Accrued Marketing Expenses AccruedMarketingExpenses	2141000	USD
CY2013Q4	ehth	Accrued Marketing Expenses AccruedMarketingExpenses	8227000	USD
	ehth	Amortization Of Book Of Business Consideration AmortizationOfBookOfBusinessConsideration	2548000	USD
	ehth	Amortization Of Book Of Business Consideration AmortizationOfBookOfBusinessConsideration	1805000	USD
CY2013Q4	ehth	Commissions Receivable Net Current CommissionsReceivableNetCurrent	2264000	USD
CY2014Q2	ehth	Commissions Receivable Net Current CommissionsReceivableNetCurrent	5758000	USD
CY2014Q2	ehth	Customer Care And Enrollment Expense CustomerCareAndEnrollmentExpense	8984000	USD
	ehth	Customer Care And Enrollment Expense CustomerCareAndEnrollmentExpense	18697000	USD
CY2013Q2	ehth	Customer Care And Enrollment Expense CustomerCareAndEnrollmentExpense	7812000	USD
	ehth	Customer Care And Enrollment Expense CustomerCareAndEnrollmentExpense	14978000	USD
	ehth	Increase Decrease In Accrued Marketing Expenses IncreaseDecreaseInAccruedMarketingExpenses	-575000	USD
	ehth	Increase Decrease In Accrued Marketing Expenses IncreaseDecreaseInAccruedMarketingExpenses	-6086000	USD
	ehth	Increase Decrease In Deferred Rent Expense IncreaseDecreaseInDeferredRentExpense	34000	USD
CY2014Q2	ehth	Incremental Common Shares Attributable To Options IncrementalCommonSharesAttributableToOptions	623000	shares
CY2013Q2	ehth	Incremental Common Shares Attributable To Options IncrementalCommonSharesAttributableToOptions	445000	shares
	ehth	Incremental Common Shares Attributable To Options IncrementalCommonSharesAttributableToOptions	453000	shares
	ehth	Incremental Common Shares Attributable To Options IncrementalCommonSharesAttributableToOptions	702000	shares
	ehth	Incremental Common Shares Attributable To Restricted Stock Units IncrementalCommonSharesAttributableToRestrictedStockUnits	117000	shares
	ehth	Incremental Common Shares Attributable To Restricted Stock Units IncrementalCommonSharesAttributableToRestrictedStockUnits	205000	shares
CY2013Q2	ehth	Incremental Common Shares Attributable To Restricted Stock Units IncrementalCommonSharesAttributableToRestrictedStockUnits	105000	shares
CY2014Q2	ehth	Incremental Common Shares Attributable To Restricted Stock Units IncrementalCommonSharesAttributableToRestrictedStockUnits	174000	shares
CY2013Q2	ehth	Other Revenue OtherRevenue	4858000	USD
	ehth	Other Revenue OtherRevenue	9431000	USD
	ehth	Other Revenue OtherRevenue	9814000	USD
CY2014Q2	ehth	Other Revenue OtherRevenue	4068000	USD
	ehth	Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Vested In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsVestedInPeriodGrantDateFairValue	3200000	USD
	ehth	Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Vested In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsVestedInPeriodGrantDateFairValue	9800000	USD
CY2014Q2	ehth	Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Vested In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsVestedInPeriodGrantDateFairValue	1400000	USD
CY2013Q2	ehth	Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Vested In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsVestedInPeriodGrantDateFairValue	1200000	USD
	ehth	Sharebased Compensationby Sharebased Payment Award Plan Adjustment Reductionin Shares Availablefor Grant SharebasedCompensationbySharebasedPaymentAwardPlanAdjustmentReductioninSharesAvailableforGrant	98000	shares
CY2014Q2	ehth	Shares Surrendered To Satisfy Tax Withholding Requirements SharesSurrenderedToSatisfyTaxWithholdingRequirements	275493	shares
	ehth	Technology And Content Expense TechnologyAndContentExpense	14468000	USD
	ehth	Technology And Content Expense TechnologyAndContentExpense	20017000	USD
CY2014Q2	ehth	Technology And Content Expense TechnologyAndContentExpense	9550000	USD
CY2013Q2	ehth	Technology And Content Expense TechnologyAndContentExpense	7727000	USD
CY2014Q2	ehth	Treasury Stock Average Cost Per Share Acquired TreasuryStockAverageCostPerShareAcquired	17.69
CY2013Q4	ehth	Treasury Stock Average Cost Per Share Acquired TreasuryStockAverageCostPerShareAcquired	16.11
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Period End Date DocumentPeriodEndDate	2014-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001333493
CY2014Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17767133	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	eHealth, Inc.
	dei	Trading Symbol TradingSymbol	EHTH

Files In Submission

Name	View Source	Status
0001333493-14-000060-index-headers.html	Edgar Link	pending
0001333493-14-000060-index.html	Edgar Link	pending
0001333493-14-000060.txt	Edgar Link	pending
0001333493-14-000060-xbrl.zip	Edgar Link	pending
ehth-20140630.xml	Edgar Link	completed
ehth-20140630.xsd	Edgar Link	pending
ehth-20140630_cal.xml	Edgar Link	unprocessable
ehth-20140630_def.xml	Edgar Link	unprocessable
ehth-20140630_lab.xml	Edgar Link	unprocessable
ehth-20140630_pre.xml	Edgar Link	unprocessable
ehth6301410q.htm	Edgar Link	pending
ehth63014exhibit101.htm	Edgar Link	pending
ehth63014exhibit102.htm	Edgar Link	pending
ehth63014exhibit311.htm	Edgar Link	pending
ehth63014exhibit312.htm	Edgar Link	pending
ehth63014exhibit321.htm	Edgar Link	pending
ehth63014exhibit322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EHTH
eHealth, Inc. Stock $ehth

2014 Q2 Form 10-Q Financial Statement

#000133349314000060 Filed on August 08, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EHTH eHealth, Inc. Stock $ehth

2014 Q2 Form 10-Q Financial Statement

#000133349314000060 Filed on August 08, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EHTH
eHealth, Inc. Stock $ehth